LifeStance Health Group, Inc. provided earnings guidance for the third quarter of 2023. For the third quarter of 2023, the company expects total revenue of $250 million to $260 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.28 USD | -0.19% |
|
-2.58% | -32.57% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.57% | 2.02B | |
+25.01% | 89.22B | |
-22.75% | 76.59B | |
+3.24% | 26.87B | |
-8.76% | 17.41B | |
+1.00% | 17.25B | |
+0.23% | 15.25B | |
+78.95% | 13.43B | |
+71.14% | 13.26B | |
-24.74% | 13.22B |
- Stock Market
- Equities
- LFST Stock
- News LifeStance Health Group, Inc.
- LifeStance Health Group, Inc. Provides Earnings Guidance for the Third Quarter of 2023